RXRX
Price
$4.83
Change
+$0.06 (+1.26%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
2.08B
50 days until earnings call
TERN
Price
$7.31
Change
+$0.18 (+2.52%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
623.95M
63 days until earnings call
Interact to see
Advertisement

RXRX vs TERN

Header iconRXRX vs TERN Comparison
Open Charts RXRX vs TERNBanner chart's image
Recursion Pharmaceuticals
Price$4.83
Change+$0.06 (+1.26%)
Volume$158.85K
Capitalization2.08B
Terns Pharmaceuticals
Price$7.31
Change+$0.18 (+2.52%)
Volume$12.43K
Capitalization623.95M
RXRX vs TERN Comparison Chart in %
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXRX vs. TERN commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a StrongBuy and TERN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (RXRX: $4.77 vs. TERN: $7.13)
Brand notoriety: RXRX and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 96% vs. TERN: 74%
Market capitalization -- RXRX: $2.08B vs. TERN: $623.95M
RXRX [@Biotechnology] is valued at $2.08B. TERN’s [@Biotechnology] market capitalization is $623.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, TERN is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 6 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • RXRX’s TA Score: 6 bullish, 4 bearish.
  • TERN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than TERN.

Price Growth

RXRX (@Biotechnology) experienced а +3.25% price change this week, while TERN (@Biotechnology) price change was -2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.28%. For the same industry, the average monthly price growth was +6.89%, and the average quarterly price growth was +33.83%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 05, 2025.

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.08B) has a higher market cap than TERN($624M). TERN YTD gains are higher at: 28.700 vs. RXRX (-29.438). TERN has higher annual earnings (EBITDA): -105M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. TERN (315M). TERN has less debt than RXRX: TERN (1.13M) vs RXRX (88.1M). RXRX has higher revenues than TERN: RXRX (64.5M) vs TERN (0).
RXRXTERNRXRX / TERN
Capitalization2.08B624M334%
EBITDA-583.64M-105M556%
Gain YTD-29.43828.700-103%
P/E RatioN/AN/A-
Revenue64.5M0-
Total Cash525M315M167%
Total Debt88.1M1.13M7,776%
TECHNICAL ANALYSIS
Technical Analysis
RXRXTERN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSCLX33.01N/A
N/A
Goldman Sachs Large Cap Gr Insghts Svc
FRSLX27.98N/A
N/A
Nuveen Small/Mid Cap Growth Opp A
ARYCX25.56N/A
N/A
American Century Real Estate C
JBAWX31.66N/A
N/A
JHancock Balanced R6
FSYKX11.05N/A
N/A
Fidelity Advisor Sustainable EM Eq C

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-1.38%
SYRE - TERN
49%
Loosely correlated
-5.18%
VRDN - TERN
47%
Loosely correlated
-4.56%
BEAM - TERN
45%
Loosely correlated
+3.30%
XNCR - TERN
45%
Loosely correlated
-1.28%
CRBU - TERN
44%
Loosely correlated
+1.67%
More